Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 4/20 | 0.43 |
| ▸ | OTC | P00480 | 1/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 6/20 | 0.38 |
| ▸ | NOS1 | P29475 | 4/20 | 0.38 |
| ▸ | NOS3 | P29474 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15546760 | 1.00 | DDAH1 (0.43) | DDAH1OTCDPP8DPP7DPP4 | |
| SCHEMBL15618248 | 1.00 | DDAH1 (0.43) | DDAH1OTCDPP8DPP7DPP4 | |
| Hydrochloric Acid SCHEMBL23629020 | 0.99 | DDAH1 (0.42) | DDAH1OTCDPP8DPP7DPP4 | |
| Hydrochloric Acid SCHEMBL23629018 | 0.99 | DDAH1 (0.42) | DDAH1OTCDPP8DPP7DPP4 | |
| SCHEMBL20178606 | 0.96 | OTC (0.46) | DDAH1OTCDPP8DPP7DPP4 | |
| SCHEMBL16446997 | 0.96 | OTC (0.46) | DDAH1OTCDPP8DPP7DPP4 | |
| SCHEMBL16446646 | 0.94 | DDAH1 (0.42) | DDAH1OTCDPP8DPP7DPP4 | |
| SCHEMBL15618151 | 0.91 | DDAH1 (0.42) | DDAH1OTCNOS2NOS1NOS3 | |
| SCHEMBL15618277 | 0.90 | DDAH1 (0.43) | DDAH1OTCNOS2NOS1NOS3 | |
| SCHEMBL15618149 | 0.90 | DDAH1 (0.43) | DDAH1OTCNOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577197-B2 | Methods of preparing N6-((2-azidoethoxy)carbonyl)lysine | SANOFI (FR) | 2026-03-17 | — | — | US | disclosed |
| US-12577197-B2 | Methods of preparing N6-((2-azidoethoxy)carbonyl)lysine | SANOFI (FR) | 2026-03-17 | — | — | US | disclosed |
| WO-2023029416-A1 | HUMAN INTERLEUKIN 2-POLYETHYLENE GLYCOL CONJUGATE AND APPLICATION THEREOF | 浙江新码生物医药有限公司 | 2023-03-09 | — | — | WO | disclosed |
| WO-2023004687-A1 | UNNATURAL AMINO ACID AND APPLICATION THEREOF, RECOMBINANT PROTEIN CONTAINING SAME, AND RECOMBINANT PROTEIN CONJUGATE | 浙江新码生物医药有限公司 | 2023-02-02 | — | — | WO | disclosed |
| WO-2023004686-A1 | UNNATURAL AMINO ACID, AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME, AND RECOMBINANT PROTEIN CONJUGATE | 浙江新码生物医药有限公司 | 2023-02-02 | — | — | WO | disclosed |
| US-20220324792-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2022-10-13 | — | — | US | disclosed |
| US-20220324792-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2022-10-13 | — | — | US | disclosed |
| CN-115087634-A | Method for preparing N6- ((2-azidoethoxy) carbonyl) lysine | 新索思股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-115087634-A | Method for preparing N6- ((2-azidoethoxy) carbonyl) lysine | 新索思股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| WO-2021133839-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021133839-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021133839-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220324792-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | JMJD6, LOX, KDM6B | DDAH1 2190/4885OTC 82/4885DPP8 1242/4885 |
| US-12577197-B2 | Methods of preparing N6-((2-azidoethoxy)carbonyl)lysine | JMJD6, PHF2, KDM2A | DDAH1 1931/4885OTC 180/4885DPP8 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.